Bulletin
Investor Alert

Boston Scientific Corp.

NYS: BSX

GO
/marketstate/country/us

After Hours

BSX
/zigman2/quotes/203726728/composite

$

37.15

Change

0.00 0.00%

Volume

Volume 364,756

Aug 4, 2020, 7:18 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/203726728/composite

Today's close

$ 38.00

$ 37.15

Change

-0.85 -2.24%

Day low

Day high

$37.08

$37.99

Open
Open: 37.78

52 week low

52 week high

$24.10

$46.62

Open

Market cap

$54.29B

Average volume

10.57M

P/E ratio

13.19

Rev. per Employee

$306,969

EPS

2.82

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/bsx

MarketWatch News on BSX

  1. Boston Scientific stock price target raised to $50 from $46 at Needham

    3:54 p.m. July 29, 2020

    - Tomi Kilgore

  2. Boston Scientific Q2 sales $2.003 bln vs. $2.631 bln; FactSet consensus $1.727 bln

    6:46 a.m. July 29, 2020

    - Ciara Linnane

  3. Boston Scientific shares up 2.7% premarket

    6:46 a.m. July 29, 2020

    - Ciara Linnane

  4. Boston Scientific Q2 loss per share 11 cents vs. EPS 11 cents

    6:44 a.m. July 29, 2020

    - Ciara Linnane

  5. Boston Scientific Q2 adj. EPS 8 cents; FactSet consensus loss 3 cents

    6:44 a.m. July 29, 2020

    - Ciara Linnane

  6. Looking for Yield? You’ll Find it Here.

    9:30 p.m. May 22, 2020

    - Barron's Online

  7. Boston Scientific misses profit, revenue estimates

    6:47 a.m. April 29, 2020

    - MarketWatch.com

  8. Boston Scientific stock price target cut to $42 from $49 at Raymond James

    7:51 a.m. April 9, 2020

    - Tomi Kilgore

  9. Boston Scientific 'significantly' cutting salaries of CEO, board of directors

    6:36 a.m. April 2, 2020

    - Tomi Kilgore

  10. Boston Scientific reducing work week schedules, cutting discretionary spending

    6:37 a.m. April 2, 2020

    - Tomi Kilgore

  11. Boston Scientific assumes Q2 impact from COVID-19 will be greater than Q1

    6:36 a.m. April 2, 2020

    - Tomi Kilgore

  12. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/bsx

Other News on BSX

  1. BioTelemetry inks sales agent agreement with Boston Scientific

    11:15 a.m. July 30, 2020

    - Seeking Alpha

  2. Oppenheimer Maintains a Hold Rating on Boston Scientific (BSX)

    7:15 p.m. July 29, 2020

    - SmarterAnalyst

  3. Boston Scientific (BSX) Received its Third Buy in a Row

    4:40 p.m. July 29, 2020

    - SmarterAnalyst

  4. Boston Scientific Q2 2020 Earnings Preview

    12:34 p.m. July 28, 2020

    - Seeking Alpha

  5. Notable earnings before Wednesday's open

    12:10 p.m. July 28, 2020

    - Seeking Alpha

  6. Acutus Medical Files For IPO For Commercialization Push

    2:47 p.m. July 23, 2020

    - Seeking Alpha

  7. FDA OKs Boston Scientific next-gen heart device

    4:36 p.m. July 21, 2020

    - Seeking Alpha

  8. Boston Scientific Mulls Billion-Dollar Snake Venom Sale -Report

    4:14 a.m. July 15, 2020

    - SmarterAnalyst

  9. Boston Scientific to sell snake venom unit - Bloomberg

    11:52 a.m. July 14, 2020

    - Seeking Alpha

  10. FDA OKs Boston Scientific cardiac monitoring system

    7:06 a.m. June 29, 2020

    - Seeking Alpha

  11. Loading more headlines...
/news/pressrelease/company/us/bsx

Press Releases on BSX

  1. Global Peripheral Artery Disease Market to Reach $5.71Billion by 2027: AMR

    9:00 a.m. Today

    - GlobeNewswire

  2. Telemonitoring Systems Market Development, Competitive Analysis, Growth Forecast 2026

    7:07 a.m. Today

    - Market Insight Reports

  3. Loading more headlines...

Rates »

Link to MarketWatch's Slice.